Spinal and General Anesthesia in Neonates Undergoing Herniorrhaphy
Launched by TANTA UNIVERSITY · Apr 2, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two types of anesthesia—spinal and general—in newborns who need surgery for inguinal hernias, which are a type of bulge in the groin area. The goal is to see which method is safer and more effective for these babies during their surgery. The study is currently recruiting participants who are either full-term or preterm newborns, ages 1 to 30 days, and of any gender. To qualify, babies must be in good health (with certain exceptions) and scheduled for surgery to repair a hernia.
If your baby is chosen to participate, they will receive either spinal or general anesthesia before the surgery. Spinal anesthesia numbs the lower part of the body, while general anesthesia makes the baby completely unconscious. Parents can expect to be involved in the process and will receive information about what the study involves and how it might benefit future patients. It's important to note that babies with certain health issues, like severe lung problems or heart conditions, cannot participate in this trial to ensure their safety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Neonates either full term or preterm.
- • Both sexes.
- • American Society of Anesthesiologists (ASA) physical status I-II
- • Undergoing unilateral or bilateral inguinal herniorrhaphy.
- Exclusion Criteria:
- • Obstructed hernia.
- • Neonates with significant chronic lung disease (e.g., disease associated with hypoxemia in room air or chronic hypercapnia).
- • Symptomatic congenital heart disease (e.g., cyanosis or congestive heart failure).
- • Symptomatic central nervous system disease (e.g., seizures).
About Tanta University
Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, Elgharbia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported